Position in DYN
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$34,855,702
+$5,651,158 QoQ
Shares Held
1,922,543
+28.8% QoQ
Ownership
1.35%
of shares outstanding
% of Portfolio
0.62%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2025
2 quarters on record
Voting authority
Sole 100.ToString("F0")%
Shared 0.ToString("F0")%
None 0.ToString("F0")%
Common Shares in DYN Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Mar 31, 2026SAMLYN CAPITAL, LLC holds $261,566,172 across 7 Biotechnology names. DYN ranks #5 (13.3% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | INSM |
INSMED Inc
|
417,205 | $68,221,360 | |
| 2 | RCUS |
Arcus Biosciences, Inc.
|
1,908,412 | $41,221,696 | |
| 3 | DNTH |
Dianthus Therapeutics, Inc. /DE/
|
431,115 | $36,179,169 | |
| 4 | RVMD |
Revolution Medicines, Inc.
|
371,948 | $36,171,943 | |
| 5 | DYN |
Dyne Therapeutics, Inc.
This page
|
1,922,543 | $34,855,702 | |
| 6 | TERN |
Terns Pharmaceuticals, Inc.
|
472,472 | $24,908,722 | |
| 7 | SYRE |
Spyre Therapeutics, Inc.
|
396,661 | $20,007,580 |
All Filings in DYN
Export CSV
2 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $34,855,702 | 1,922,543 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $29,204,544 | 1,493,075 | Shares | Defined | 2026-02-17 | |
| No filing history on record for this holder in this stock. | ||||||